Organogenesis Holdings Inc.
ORGODrug Manufacturers - Specialty & Generic
$0.77−6.20%As of Oct 30vs prior close
- Market cap
- $98.8M
- P/E (TTM)
- –
- From 52W high
- −88.26%
- EPS (LTM)
- -$0.79
- Revenue (LTM)
- $457.5M
- Net margin
- -18.40%
Nomior Score
22
Distressed LaggardBottom 8% of the scored universe
Growth46
Quality24
Value65
Momentum6
Resilience31
Growth
+16.87%revenue a year over 9 fiscal years
YE16 $138.7MLTM $457.5M
Connections
Revenue to profitQ2 YE26
The operating loss was 117% of revenue, wider by 104 pts on a year.
Who owns it
2funds